InflaRx Discontinues Pyoderma Gangrenosum Trial, Shifts Focus to INF904 with Summer 2025 Data Expected
InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 7,933,910 | $8,013,249 | +23% | 0.16% |
| 2. | 683 Capital Partners Ari Zweiman | 3,315,000 | $3,348,150 | +48% | 0.15% |
| 3. | Eversept Partners Kamran Moghtaderi | 1,757,312 | $1,774,885 | +2% | 0.09% |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 324,349 | $327,592 | +73% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 280,040 | $282,840 | -9% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,210 | $12,704 | 0% |